Progress Update from PTC Therapeutics on Spinal Muscular Atrophy Research
Recently, Fight SMA and the biopharmaceutical firm PTC Therapeutics announced they’re collaborating in the effort to discover new treatments for spinal muscular atrophy (SMA). PTC issued a progress update on that work today.
Read PTC’s progress update in PDF format here.
research, researchers, sma, smn2, spinal muscular atrophyShare This Post Via Email or Social Bookmark
(via Spinal Muscular Atrophy (SMA) Blog by Fight SMA)
